Aaron Lazorwitz

Aaron Lazorwitz, MD, PhD, is an Assistant Professor at Yale School of Medicine with a dual appointment in Family Planning and Reproductive Science. He specializes in complex family planning, providing care for patients requiring advanced contraceptive management, abortion services, and sterilization procedures. His research focuses on pharmacogenomics of hormonal contraception, aiming to personalize contraceptive counseling using genetic data.

Education:

• BA in Psychology, Johns Hopkins University (2008)
• MD, UT Southwestern Medical Center (2012)
• Residency in Obstetrics & Gynecology, University of Colorado (2016)
• Fellowship in Family Planning, University of Colorado (2018)
• PhD in Clinical Science, University of Colorado (2023)

Research Interests: Dr. Lazorwitz investigates how genetic variants influence responses to hormonal contraceptives, lifestyle effects on drug efficacy, and optimizing contraceptive implant placement/removal techniques. His work bridges clinical practice and personalized medicine.

Publications Trends: His articles address contraceptive implant pharmacokinetics, drug interactions (e.g., rifampin, topiramate), patient-reported outcomes, and improving access to reproductive care for marginalized populations.

Awards & Honors:

• NICHD Loan Repayment Program (2022, 2020)
• University of Colorado Health Excellence in Care Award (2023)
• Multiple teaching awards (2015–2018)

Grants & Advising: Leads studies funded by NIH grants, mentors trainees in family planning fellowships, and collaborates on interdisciplinary projects at Yale’s pharmacogenomics lab. Active in professional organizations like Society of Family Planning and American Congress of Obstetricians and Gynecologists.

Labs/Teams: Collaborates with the University of Colorado’s Personalized Medicine Center and Yale’s Reproductive Sciences Division. Engages in translational research linking genetic data to clinical contraceptive guidance.